Breaking News: Updates in Treatments for TNBC

November 1, 2018

Listen to this webinar about the latest treatment updates for triple-negative breast cancer, for both early-stage and metastatic disease. Our expert, Rita Nanda, MD, discussed the PARP inhibitors recently approved by the FDA, as well as other therapies in the pipeline. Learn about what these treatments could mean for you, what information you need to make treatment decisions and how to discuss your options with your healthcare provider.

More In Triple-Negative